The Food and Drug Administration considered data regarding marijuana’s medical value submitted by U.S. states with legal cannabis programs when determining how the drug should be federally classified, newly released documents suggest.
FDA considered state data in marijuana rescheduling, documents show is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
Credit:Source link